Showing results (361-370 of 403) with videos related to
Sort By:
Pageof 41
ACS Nano|January 28, 2016
Spearhead Nanometric Field-Effect Transistor Sensors for Single-Cell AnalysisYanjun Zhang, Jan Clausmeyer, Babak Babakinejad, et al.The Journal of Liquid Biopsy|June 22, 2026
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-needMohammadali Yavari Ramsheh, Raquel L Fraccari, Rossitza Christova, et al.Breast Cancer Research and Treatment|July 8, 2010
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cellsPaul T R Thiruchelvam, Chun-Fui Lai, Hui Hua, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancerR Charles Coombes, Judith M Bliss, Marc Espie, et al.Cureus|August 28, 2025
Colorectal Cancer Risk and Protective Factors Among People of African Descent: A Systematic Review and Meta-AnalysisCollins C Okeke, Angela Ojo, Onyinye E Ebiliekwe, et al.Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|July 29, 2024
Establishing a paediatric critical care core quality measure set using a multistakeholder, consensus-driven processJessica A Schults, Karina R Charles, Johnny Millar, et al.Breast Cancer Research and Treatment|August 24, 2010
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growthRobert S Tolhurst, Ross S Thomas, Fiona J Kyle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane studyJudith M Bliss, Lucy S Kilburn, Robert E Coleman, et al.Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.Pageof 41